|

Implementation Facilitation Pilot for Alcohol Use Disorder (AUD) in Alcohol-associated Liver Disease (ALD)

RECRUITINGN/ASponsored by Yale University
Actively Recruiting
PhaseN/A
SponsorYale University
Started2026-04-05
Est. completion2029-04
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT07525258

Summary

The goal of this project is to improve provision of integrated medications for alcohol use disorder (MAUD) with brief counseling for patients with alcohol use disorder (AUD) and alcohol-associated liver disease (ALD) in hepatology clinics. There are many benefits of AUD treatment among patients with AUD and ALD such as reduction in liver-related complications and hepatology clinicians providing this care in an integrated fashion can improve access and uptake.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Must provide care for patients with liver disease at a hepatology clinical location within the Yale School of Medicine and YNHH medical system.

Exclusion Criteria:

* Providers who do not treat patients with chronic liver disease and alcohol-associated liver disease.

Conditions3

Alcohol Associated Liver DiseaseAlcohol Use DisorderLiver Disease

Locations1 site

Yale School of Medicine/Yale-New Haven Health
New Haven, Connecticut, 06520

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.